Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

Acute myeloid leukemia (AML) in adults aged 60 years and older has a poor prognosis. The goal of this study was to describe the perceptions of older patients with AML regarding treatment decisions and the potential risks and benefits of treatment. Patient‐clinician concordance in estimated treatment risk and the likelihood of cure with intensive and nonintensive treatment was also examined.

[1]  J. Temel,et al.  Quality of Life, Mood, and Prognostic Understanding in Patients with Metastatic Breast Cancer. , 2016, Journal of palliative medicine.

[2]  J. Temel,et al.  Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia , 2015, Cancer.

[3]  G. Tomlinson,et al.  Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. , 2015, Journal of geriatric oncology.

[4]  L. Traeger,et al.  Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation , 2014, Bone Marrow Transplantation.

[5]  L. Traeger,et al.  Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer , 2014, Cancer.

[6]  M. Themessl-Huber,et al.  The experience of acute leukaemia in adult patients: a qualitative thematic synthesis. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[7]  M. Minden,et al.  Symptom burden and supportive care in patients with acute leukemia. , 2013, Leukemia research.

[8]  J. Temel,et al.  Predicting life expectancy in patients with advanced incurable cancer: a review. , 2013, The journal of supportive oncology.

[9]  M. Minden,et al.  Abducted by the illness: a qualitative study of traumatic stress in individuals with acute leukemia. , 2013, Leukemia research.

[10]  R. Stone.  Acute myeloid leukemia in first remission: to choose transplantation or not? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Cella,et al.  Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  Matthew D Finkelman,et al.  Patients' expectations about effects of chemotherapy for advanced cancer. , 2012, The New England journal of medicine.

[13]  M. McHugh.  Interrater reliability: the kappa statistic , 2012, Biochemia medica.

[14]  M. Minden,et al.  Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Marmar,et al.  Traumatic stress in acute leukemia , 2011, Psycho-oncology.

[16]  J. Temel,et al.  Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Jane C Weeks,et al.  End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  R. Hills,et al.  Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Minden,et al.  Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia. , 2009, Leukemia research.

[20]  M. Adachi,et al.  Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non‐small cell lung cancer , 2009, Psycho-oncology.

[21]  H. Dombret,et al.  Acute myeloid leukemia in the elderly. , 2008, Seminars in oncology.

[22]  G. Tomlinson,et al.  The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults. , 2007, Critical reviews in oncology/hematology.

[23]  E. Estey,et al.  Acute myeloid leukemia and myelodysplastic syndromes in older patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Cleary,et al.  Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  H. Gundacker,et al.  Age and acute myeloid leukemia. , 2006, Blood.

[26]  R. Batiste,et al.  Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation , 2006, Bone Marrow Transplantation.

[27]  J. Lowery,et al.  Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R M Stone,et al.  Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome , 2004, Leukemia.

[29]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[30]  E. Bruera,et al.  Patient preferences versus physician perceptions of treatment decisions in cancer care. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  D. Fairclough,et al.  Discrepancies between patient and physician estimates for the success of stem cell transplantation. , 2001, JAMA.

[32]  H. Welch,et al.  Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.

[33]  E. Cook,et al.  Relationship between cancer patients' predictions of prognosis and their treatment preferences. , 1998, JAMA.

[34]  B. Lo,et al.  Do patients want to participate in medical decision making? , 1984, JAMA.

[35]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[36]  R. Zittoun,et al.  Assessment of quality of life during intensive chemotherapy or bone marrow transplantation , 1999, Psycho-oncology.

[37]  M. Brundage,et al.  Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.